Overexpression of cathepsin B correlates with angiogenesis in colon adenocarcinoma

Neoplasma

Volumn 51, Issue 1, 2004, Pages 38-43

  Kruszewski, W J ^a   Rzepko, R ^a   Wojtacki, J ^b   Skokowski, J ^a   Kopacz, A ^a   Jaskiewicz K ^a   Drucis, K ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b PCK's Maritime Hospital in Gdynia   (Poland)

Author keywords

Adenocarcinoma; Angiogenesis; Cathepsin B; Colon; Prognosis

Indexed keywords

CATHEPSIN B; PROTEINASE; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; COLON ADENOCARCINOMA; COLORECTAL CANCER; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS;

EID: 1342344183     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. BANDER B, WHITEHOUSE R, BAKER S, SWANSON R. Tumor angiogenesis in stage II colorectal carcinoma. Association with survival. Am J Clin Pathol 1998; 109: 733-737.
2. BLEEKER FE, HAZEN LG, KOHLER A, VAN NOORDEN CJ. Direct comparison of the sensitivity of enzyme histochemical and immunohistochemical methods: cathepsin B expression in human colorectal mucosa. Acta Histochem 2000; 102: 247-257.
3. BOSSI P, VIALE G, LEE A, ALTANO R, COGGI G et al. Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res 1995; 55: 5049-5053.
4. CAMPO E, MUNOZ J, MIQUEL R, PALACIN A, CARDESA A et al. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Am J Pathol 1994; 145: 301-309.
5. CHOI H, HYUN M, JUNG G, KIM S, HONG S. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence. Oncology 1998; 55: 575-581.
6. CHUNG Y, MAEDA K, SOWA M. Prognostic value of angiogenesis in gastrointestinal tumours. Eur J Cancer 1996; 32A: 2501-2505.
7. COMPTON C, FIELDING L, BURGART L, CONLEY B, COOPER H et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 979-994.
8. DIDKOWSKA J, WOJCIECHOWSKA U, TARNOWSKI W, ZATOŃSKI W. Cancer in Poland in 1999. Polish National Cancer Registry. The Maria-Sklodowska-Curie Memorial Cancer Center and Institute of Oncology. Warsaw 2002: 19-68.
9. DIRIX L, VERMEULEN P, VAN OOSTEROM A, GASPARINI G. Microvascular count and prognosis in colorectal cancer. J Clin Oncol 1996; 14: 2400-2403.
10. DOHCHIN A, SUZUKI J, SEKI H, MASUTANI M, SHIROTO H et al. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer 2000; 89: 482-487.
11. ENGELS C, BENETT S, CHAMBERS A, DOIG G, KERKVLIET N et al. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Pathol 1996; 20: 1260-1265.
12. FOLKMAN J, SWING Y. Angiogenesis. J Biol Chem 1992; 267: 10931-10934.
13. HACKEL CG, KRUEGER S, GROTE HJ, OSHIRO Y, HODGES S et al. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma. Cancer 2000; 89: 995-1003.
14. HACZYIŃSKA H, WARWAS M. Tissue cathepsin B as a prognostic factor in patients with cancer. Nowotwory 1997; 47: 587-594.
15. HAMILTON SR, AALTONEN LA. Pathology and Genetics of Tumours of the Digestive System. WHO Classification of Tumours. Lyon, IARC Press, 2000.
16. HAZEN LG, BLEEKER FE, LAURITZEN B, BAHNS S, SONG J et al. Comparative localization of cathepsin B protein and activity in colorectal cancer. J Histochem Cytochem 2000; 48: 1421-1430.
17. HECHT J. Metastasis in colorectal cancer: what makes the tumor aggressive? Eur J Surg 1998; Suppl 582: 104-110.
18. HERSZENYI L, PLEBANI M, CARRAO P, DE PAOLI M, ROVERONI G et al. Proteases in gastrointestinal neoplastic disease. Clin Chim Acta 2000; 291: 171-187.
19. HERSZENYI L, PLEBANI M, CARRAO P, DE PAOLI M, ROVERONI G et al. The role of cysteine and serine proteases in colorectal carcinoma. Cancer 1999; 86: 1135-1142.
20. HIRAI K, YOKOYAMA M, ASANO G, TANAKA S. Expression of cathepsin B and cystatin C in human colorectal cancer. Hum Pathol 1999; 30: 680-686.
21. JESSUP J. Cathepsin B and other proteases in human colorectal carcinoma. Am J Pathol 1994; 145: 253-262.
22. JOHNSON P, ALLEGRA C. Colorectal cancer biology: clinical implications. Semin Oncol 1995; 22: 418-432.
23. KEPPLER D, SAMENI M, MOIN K, MIKKELSEN T, DIGLIO CA et al. Tumor progression and angiogenesis: cathepsin B & Co. Biochem Cell Biol 1996; 74: 799-810.
24. KHAN A, KRISHNA M, BAKER S, BANNER B. Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinoma. Mod Pathol 1998; 11: 704-708.
25. KONERDING MA, FAIT E, GAUMANN A. 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br J Cancer 2001; 84: 1354-1362.
26. KRUSZEWSKI WJ, RZEPKO R, WOJTACKI J, KOPACZ A, ZÓŁTOWSKA A et al. Von Willebrand factor and CD31 in colorectal cancer angiogenesis investigation. Pol Przegl Chir 2001; 73: 509-520.
27. LAH TT, CERCEK M, BLEJEC A, KOS J, GORODETSKY E et al. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators. Clin Cancer Res 2000; 6: 578-584.
28. LINDMARK G, GERDIN B, SUNDBERG CH, PAHLMAN L, BERGSTROM R et al. Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol 1996; 14: 461-466.
29. MCKERROW JH, BHARGAVA V, HANSELL E, HULING S, KUWAHARA T et al. A functional proteomics screen of proteases in colorectal carcinoma. Mol Med 2000; 6: 450-460.
30. MOOTERI S, RUBIN D, LEURGANS S, JAKATE S, DRAB E et al. Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum 1996; 39: 1073-1080.
31. NIEDERGETHMANN M, HILDENBRAND R, WOLF G, VERBEKE CS, RICHTER A et al. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcionoma after curative resection. Int J Pancreatol 2000; 28: 31-39.
32. OHTANI H, SASANO N. Microvascular changes in the stroma of human colorectal carcinomas: ultrastructural histochemical study. Jpn J Cancer Res 1989; 80: 360-365.
33. PAVLOPOULOS P, KONSTANTINIDOU A, AGAPITOS E, KAVATZAS N, NIKOLOPOULOU P et al. A morphometric study of neovascularization in colorectal carcinoma. Cancer 1998; 83: 2067-2075.
34. DEL RE EC, SHUJA S, CAI J, MURNANE MJ. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas. Br J Cancer 2000; 82: 1317-1326.
35. RAK J, FILMUS J, WERBEL R. Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur J Cancer 1996; 32A: 2438-2450.
36. RZEPKO R, PIKTEL A, KRUSZEWSKI W, IZYCKA-ŚWIESZEWSKA E. Angiogenesis in colorectal adenocarcinoma - comparison with vascular pattern of colon wall. Proktologia 2001; 2: 263-273.
37. SACLARIDES T. Angiogenesis In colorectal cancer. Surg Clin North Am 1997; 77: 253-260.
38. SCHWARTZ M. Tissue cathepsins as tumor markers. Clin Chim Acta 1995; 237: 67-78.
39. SHAHEEN RM, AHMAD SA, LIU W, REINMUTH N, JUNG YD et al. Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors. Br J Cancer 2001; 85: 584-589.
40. SOBIN L, editor. TNM. An illustrated resorce for the classification and staging of malignant tumours. International Union Against Cancer. CD-ROM copyright. Atlanta, Georgia, USA: Willey-Liss Inc. and Med Ascend Inc., 1998: 109-111.
41. SZPADERSKA AM, FRANKFATER A. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res 2001; 61: 3493-3500.
42. TAKEBAYASHI Y, AKIYAMA S, HAMADA K, SKIBA S, AIKOU T. Angiogenesis as an unfavourable prognostic factor in human colorectal carcinoma. Cancer 1996; 78: 226-231.
43. TANIGAWA N, AMNAYA H, MATSUMURA M, LU C, KITAOKA A et al. Tumor angiogenesis and mode of metastasis in patient with colorectal cancer. Cancer Res 1997; 57: 1043-1046.
44. TOMISTKI S, OHNO S, ICHIYOSHI Y, KUWANO H, MAEHARA Y et al. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 1996; 77: 1722-1728.
45. VERMEULEN P, GASPARINI G, FOX S, TOI M, MARTIN L et al. Quantification of angiogenesis in solid human tumours: an International Consensus on the Methodology and Criteria of Evaluation. Eur J Cancer 1996; 32A: 2474-2484.
46. VIGNESWARAN N, ZHAO W, DASSANAYAKE A, MULLE S, MILLER DM et al. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum Pathol 2000; 31: 931-937.
47. WEIDNER N, SEMPLE J, WELCH W, FOLKMAN. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
48. WIGGERS T, ARENDS J, SCHUTTE B, VOLOVICS L, BOSMAN F. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 1988; 61: 386-395.
49. ZANETTA L, MARCUS SG, VASILE J, DOBRYANSKY M, COHEN H et al. Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis. Int J Cancer 2000; 85: 281-288.